Good MorningThe tug of war between the bulls and bears continued on Wednesday leaving the broad market S&P 500 lower for the session. The Dow Jones Industrial Average closed with a smaller loss but the real story is about Tech and Transports. On the one hand, shares of tech heavyweight remain under pressure keeping the NASDAQ Composite behind its peers and down 2.0%. On the other hand, the Dow Jones Transportation Average gained nearly 2.0% at its high to close just shy of another new all-time high.
One reason for the dislocation in trading is rising interest rates. Rising interest rates make growth more costly for the tech sector and that will cut into their earnings. This situation makes the transports and other dividend-paying blue chips more attractive than ever before but the real test for the markets will be on Friday, however, with the release of core consumer inflation data.
Featured: Elon’s big $266,000 per second purchase (Ad) 
|
Business Services | |
Steelcase Is Why Stock Picking Matters
We don’t want to single out Steelcase (NYSE:SCS) as a bad investment because it’s not. What it is is a uniquely positioned company within a very good industry. While furniture company’s like At Home Group (NYSE: HOME) and Haverty have seen... Read the Full Story |
|
From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
|
Medical | |
Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) stock lost half its value from its 2021 highs during the March Nasdaq correction. Shares are attempting to rebound as marijuana legalization and decriminalization tailwinds continue to accelerate as evidenced by New York is edging closer to... Read the Full Story |
|
Business Services | | Similar to how stocks that are related to cryptocurrency, cannabis, and electric vehicles rallied on heavy volume a few months back, we are witnessing new speculative trading activity in companies that are involved in the non-fungible token (NFT) space. If you aren’t familiar with NFTs, they a... Read the Full Story |
|
From Our Partners | | Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. | | Watch the documentary briefing and find out which side you land on |
|
Medical | | When multiple analysts have a favorable opinion on a stock it can be an overwhelming buy signal. Although it doesn't mean the investment doesn't have its risk factors, a green light from an army of Wall Street firms generally means the company has a very bright outlook.
It won't come as a surprise ... Read the Full Story |
|
Technology | |
Shares of Blink Charging (NASDAQ:BLNK) are down sharply in advance of the company’s earnings report. Is this an example of investors preparing for good news, or is it a sell-off in advance of a disappointing report?
At this point, I’m going to say it really doesn’t matter. Blink... Read the Full Story |
|
From Our Partners | | Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now.
Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen.
Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch. | | Watch how to access the legal backdoor before it closes. |
|
Technology | | Shares of software giant Adobe (NASDAQ: ADBE) found themselves down slightly in yesterday’s session despite posting solid earnings on Tuesday evening. They’d been trading fairly sideways since the last quarter of 2020 but had been starting to trend down this month as the cyclical rotatio... Read the Full Story |
|
Retail/Wholesale | |
Shoe Carnival Is No House Of Horrors For Investors
Shoe Carnival (NASDAQ: SCVL) is one of those underappreciated pandemic winners that just keeps on delivering. The company’s efforts in eCommerce and safe store operations have driven the company to great success and have it on track for Y... Read the Full Story |
|
Retail/Wholesale | | Best Buy (NYSE: BBY) is a little like the character from “Monty Python and the Holy Grail,” who shouts, “Not dead yet” as undertakers try to cart him away.
It was less than a decade ago that the big-box electronics retailer seemed to be on its last legs, losing customers to... Read the Full Story |
|
Energy | |
Solar energy solutions provider First Solar (NASDAQ: FSLR) stock saw a parabolic spike heading into 2021 thanks to the clean and renewable energy and environmental, sustainable and governance (ESG) investment themed momentum driven by the global decarbonization initiatives adopted by the Biden Adm... Read the Full Story |
|
Finance | | Every once in a while, a company like Upstart Holdings (NASDAQ:UPST) comes along and completely catches the market off-guard with an unexpectedly strong earnings report. This can result in institutional investors acquiring shares at a rapid rate and driving the share price up quickly. This is most l... Read the Full Story |
|
The Early Bird Stock Of The Day Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas. | | View Today's Stock Pick |
|
